Daniel A. Pollyea, MD, MS

Column

Navigating the Complexities of Novel Treatment Sequencing for AML

03/16/2020

This section called “CME Corner,” highlights, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers. Articles include an overview of a specific area where key...

This...

03/16/2020

Journal of Clinical Pathways

Magrolimab in Combination With Azacitidine for Patients With Untreated Higher-Risk Myelodysplastic Syndromes: 5F9005 Phase 1b Study Results

Introduction:

Deepa Jeyakumar ;

Eunice S. Wang ;

Mark P. Chao ;

Ian W. Flinn ;

Indu Lal ;

Joshua F. Zeidner ;

David A. Sallman ;

Daniel A. Pollyea , MD, MS;

Guillermo Garcia-Manero , MD;

Naval G. Daver ;

Carol O'Hear ;

Paresh Vyas ;

Joseph G. Jurcic ;

Suman N. Kambhampati ;

Lin Gu ;

Monzr M. Al Malki ;

Anderson Tan ;

Adam Asch ;

Tiffany N. Tanaka ;

Terrence J. Bradley ;

11/04/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Daniel A. Pollyea, MD, MS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products